91Â鶹ÌìÃÀÖ±²¥

Journal Article

1. Kagawa H, Stringham J, Selzman C, Goodwin M, Frye L, Raman S, Cahill B, Morrell M (2023). Case Report of Needle Disruption of the Retroperitoneal Lymph Nodes for Refractory Chylothorax After Double Lung Transplantation. Transplant Proc, 55(8), 1981-1983. ()
2. Fredrick SR, Iasella CJ, Sacha LM, Rivosecchi RM, Morrell MR, Sanchez PG, Pilewski JM, Snyder ME, McDyer JF, Moore CA (2023). Incidence of Acute Cellular Rejection After Granulocyte Colony-Stimulating Factor in Lung Transplant Recipients. J Pharm Pract, 8971900231184308. ()
3. Vendetti ML, Esther Moon SJ, Imes CC, Hergenroeder A, Sciurba F, Lendermon E, Pilewski J, Ren D, Parmanto B, Dewhirst B, Willey B, Jones K, Morrell MR, Sanchez P, DeVito Dabbs A (2023). Design of Lung Transplant Go (LTGO): A randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation. Contemp Clin Trials Commun, 33, 101097. ()
4. Hyzny EJ, Chan EG, Malik SM, Morrell M, Furukawa M, Ryan JP, Sanchez PG (2022). Risk Factors and Outcomes of Postoperative Hepatic Dysfunction After Lung Transplantation. Ann Thorac Surg. ()
5. Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, Rothenberger S, McMahon DK, Crandall MD, Sobolewksi MD, Nathan Enick P, Jacobs JL, Collins K, Klamar-Blain C, Macatangay BJC, Parikh UM, Heaps A, Coughenour L, Schwartz MB, Dueker JM, Silveira FP, Keebler ME, Humar A, Luketich JD, Morrell MR, Pilewski JM, McDyer JF, Pappu B, Ferris RL, Marks SM, Mahon J, Mulvey K, Hariharan S, Updike GM, Brock L, Edwards R, Beigi RH, Kip PL, Wells A, Minnier T, Angus DC, Mellors JW (2021). Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS). Clin Infect Dis, 75(1), e630-e644. ()
6. Chan EG, Hyzny EJ, Furukawa M, Ryan JP, Subramaniam K, Morrell MR, Pilewski J, Luketich JD, Sanchez PG (2022). Intraoperative Support for Primary Bilateral Lung Transplantation: A Propensity Matched Analysis. Ann Thorac Surg. ()
7. Chan EG, Hyzny EJ, Ryan JP, Morrell MR, Pilewski J, Sanchez PG (2021). Outcomes following lung re-transplantation in patients with cystic fibrosis. J Cyst Fibros, 21(3), 482-488. ()
8. Furukawa M, Chan EG, Morrell MR, Ryan JP, Rivosecchi RM, Iasella CJ, Lendermon EA, Pilewski JM, Sanchez PG (2022). Risk factors of bronchial dehiscence after primary lung transplantation. J Card Surg, 37(4), 950-957. ()
9. Harano T, Chan EG, Furukawa M, Reck Dos Santos P, Morrell MR, Sappington PL, Sanchez PG (2021). Oxygenated right ventricular assist device with a percutaneous dual-lumen cannula as a bridge to lung transplantation. J Thorac Dis, 14(4), 832-840. ()
10. Haidar G, Agha M, Bilderback A, Lukanski A, Linstrum K, Troyan R, Rothenberger S, McMahon DK, Crandall MD, Sobolewksi MD, Enick PN, Jacobs JL, Collins K, Klamar-Blain C, Macatangay BJC, Parikh UM, Heaps A, Coughenour L, Schwartz MB, Dueker JM, Silveira FP, Keebler ME, Humar A, Luketich JD, Morrell MR, Pilewski JM, McDyer JF, Pappu B, Ferris RL, Marks SM, Mahon J, Mulvey K, Hariharan S, Updike GM, Brock L, Edwards R, Beigi RH, Kip PL, Wells A, Minnier T, Angus DC, Mellors JW (2022). Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study. Clin Infect Dis, 4(6), 1115-1130. ()
11. Moon SJE, Dabbs AD, Hergenroeder AL, Vendetti ML, Jones KB, Willey BM, Morrell MR, Imes CC (2021). Considerations for assessing physical function and physical activity in clinical trials during the COVID-19 pandemic. Contemp Clin Trials, 105, 106407. ()
12. Christie IG, Chan EG, Ryan JP, Harano T, Morrell M, Luketich JD, Sanchez PG (2020). National Trends in Extended Criteria Donor Utilization and Outcomes for Lung Transplantation. Ann Thorac Surg, 111(2), 421-426. ()
13. Harano T, Ryan JP, Chan EG, Noda K, Morrell MR, Luketich JD, Sanchez PG (2020). Lung transplantation for the treatment of irreversible acute respiratory distress syndrome. Clin Transplant, 35(2), e14182. ()
14. Harano T, Ryan JP, Morrell MR, Luketich JD, Sanchez PG (2021). Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation. ASAIO J, 67, 1071-1078. ()
15. Chan EG, Chan PG, Harano T, Ryan JP, Morrell MR, Sanchez PG (2020). Trends in Lung Transplantation Practices Across the United States During the COVID-19 Pandemic. Transplantation, 105(1), 187-192. ()
16. Harano T, Rivosecchi RM, Morrell MR, Sanchez PG (2020). Dabigatran reversal with idarucizumab prior to lung transplantation. Clin Transplant, 35(1), e14142. ()
17. Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A (2020). Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. J Heart Lung Transplant, 39(12), 1417-1425. ()
18. Iasella CJ, Hoji A, Popescu I, Wei J, Snyder ME, Zhang Y, Xu W, Iouchmanov V, Koshy R, Brown M, Fung M, Langelier C, Lendermon EA, Dugger D, Shah R, Lee J, Johnson B, Golden J, Leard LE, Ellen Kleinhenz M, Kilaru S, Hays SR, Singer JP, Sanchez PG, Morrell MR, Pilewski JM, Greenland JR, Chen K, McDyer JF (2020). Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction. Am J Transplant, 21, 2145-2160. ()
19. Chan EG, Morrell MR, Chan PG, Sanchez PG (2020). Bilateral sequential lung transplantation in Jehovah's Witnesses. Perfusion, 36, 267659120939364. ()
20. Chan EG, Hayanga JWA, Tuft M, Morrell MR, Sanchez PG (2021). Access to Lung Transplantation in the United States: The Potential Impact of Access to a High-volume Center. Transplantation, 104(7), e199-e207. ()
21. Samanta P, Clancy CJ, Marini RV, Rivosecchi RM, McCreary EK, Shields RK, Falcione BA, Viehman A, Sacha L, Kwak EJ, Silveira FP, Sanchez PG, Morrell M, Clarke L, Nguyen MH (2020). Isavuconazole is as effective as and better tolerated than voriconazole for antifungal prophylaxis in lung transplant recipients. Clin Infect Dis. ()
22. Iasella CJ, Winters SA, Kois A, Cho J, Hannan SJ, Koshy R, Moore CA, Ensor CR, Lendermon EA, Morrell MR, Pilewski JM, Sanchez PG, Kass DJ, Alder JK, Nouraie SM, McDyer JF (2020). Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. Am J Transplant, 20(5), 1439-1446. ()
23. Nolley E, Fleck J, Kavalieratos D, Dew MA, Dilling D, Colman R, Crespo MM, Goldberg H, Hays S, Hachem R, Lease E, Lee J, Reynolds J, Morrell M, Schenker Y (2020). Lung Transplant Pulmonologists' Views of Specialty Palliative Care for Lung Transplant Recipients. J Palliat Med, 23(5), 619-626. ()
24. Harano T, DCunha J, Kilaru S, Morrell MR, Luketich JD, Sanchez PG (2019). Extracorporeal Membrane Oxygenation to Overcome Graft-Cavity Disparity of Lung Transplantation. Ann Thorac Surg, 109(4), e275-e277. ()
25. Jorge A, Sanchez PG, Hayanga JWA, Pilewski JM, Morrell M, Tuft M, Ryan J, DCunha J (2019). Routine deep vein thrombosis screening after lung transplantation: Incidence and risk factors. J Thorac Cardiovasc Surg, 159(3), 1142-1150. ()
26. Thanukrishnan H, Corcoran TE, Iasella CJ, Moore CA, Nero JA, Morrell MR, McDyer JF, Hussain S, Nguyen MH, Venkataramanan R, Ensor CR (2019). Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis. Transplantation, 103(12), 2608-2613. ()
27. Morrell MR, Kiel SC, Pilewski JM (2019). Organ Transplantation for Cystic Fibrosis. Semin Respir Crit Care Med, 40(6), 842-856. ()
28. Nolley EP, DeSensi R, Nouraie M, Schenker Y, Morrell MR (2019). Characteristics, Trends, and Predictors of Specialty Palliative Care Utilization after Lung Transplantation. J Palliat Med, 22(9), 1092-1098. ()
29. Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ (2018). Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome. Transplantation, 103(5), 1036-1042. ()
30. Popescu I, Mannem H, Winters SA, Hoji A, Silveira F, McNally E, Pipeling MR, Lendermon EA, Morrell MR, Pilewski JM, Hanumanthu VS, Zhang Y, Gulati S, Shah PD, Iasella CJ, Ensor CR, Armanios M, McDyer JF (2018). Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres. Am J Respir Crit Care Med, 199(3), 362-376. ()
31. Hamad Y, Pilewski JM, Morrell M, DCunha J, Kwak EJ (2019). Outcomes in Lung Transplant Recipients With Mycobacterium abscessus Infection: A 15-Year Experience From a Large Tertiary Care Center. Transplant Proc, 51(6), 2035-2042. ()
32. Lichvar AB, Ensor CR, Zeevi A, Morrell MR, Pilewski JM, Hayanga JWA, DCunha J, McDyer JF, Petrov AA (2018). Detrimental Association of Hypogammaglobulinemia With Chronic Lung Allograft Dysfunction and Death Is Not Mitigated by On-Demand Immunoglobulin G Replacement After Lung Transplantation. Prog Transplant, 1526924818817028. ()
33. Ensor CR, Goehring KC, Iasella CJ, Moore CA, Lendermon EA, McDyer JF, Morrell MR, Sciortino CM, Venkataramanan R, Wiland AM (2018). Belatacept for maintenance immunosuppression in cardiothoracic transplantation: The potential frontier. Clin Transplant, 32(10), e13363. ()
34. Kim F, Dezfulian C, Empey PE, Morrell M, Olsufka M, Scruggs S, Kudenchuk P, May S, Maynard C, Sayre MR, Nichol G (2018). Usefulness of Intravenous Sodium Nitrite During Resuscitation for the Treatment of Out-of-Hospital Cardiac Arrest. Am J Cardiol, 122(4), 554-559. ()
35. Ensor CR, Iasella CJ, Harrigan KM, Morrell MR, Moore CA, Shigemura N, Zeevi A, McDyer JF, Venkataramanan R (2018). Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients. Am J Transplant, 18(6), 1527-1533. ()
36. Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR (2018). Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients. Clin Transplant, 32(5), e13235. ()
37. Naik C, Moore C, Pipeling M, DCunha J, Ruppert K, Ensor C, Morrell M (2018). Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation. Transplant Direct, 4(5), e350. ()
38. Hess NR, Esper SA, Awori Hayanga JW, Tuft M, Morrell M, DCunha J (2018). Patent foramen ovale repair at the time of double lung transplantation: Necessary or not? Clin Transplant, e13201. ()
39. Iasella CJ, Winstead RJ, Moore CA, Johnson BA, Feinberg AT, Morrell MR, Hayanga JWA, Lendermon EA, Zeevi A, McDyer JF, Ensor CR (2017). Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors. Transplantation, 102(1), 171-177. ()
40. Hayanga AJ, Du AL, Joubert K, Tuft M, Baird R, Pilewski J, Morrell M, DCunha J, Shigemura N (2017). Mechanical Ventilation and Extracorporeal Membrane Oxygenation as a Bridging Strategy to Lung Transplantation: Significant Gains in Survival. Am J Transplant, 18(1), 125-135. ()
41. Hayanga JWA, Shigemura N, Aboagye JK, Ensor C, Dew MA, Hayanga HK, Esper SA, Joubert K, Morrell MR, DCunha J (2017). ECMO Support in Lung Transplantation: A Contemporary Analysis of Hospital Charges in the United States. Ann Thorac Surg, 104(3), 1033-1039. ()
42. Moore CA, Pilewski JM, Venkataramanan R, Robinson KM, Morrell MR, Wisniewski SR, Zeevi A, McDyer JF, Ensor CR (2017). Effect of aerosolized antipseudomonals on Pseudomonas positivity and bronchiolitis obliterans syndrome after lung transplantation. Transpl Infect Dis, 19(3). ()
43. Ensor CR, Yousem SA, Marrari M, Morrell MR, Mangiola M, Pilewski JM, DCunha J, Wisniewski SR, Venkataramanan R, Zeevi A, McDyer JF (2017). Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. Am J Transplant, 17(5), 1380-1388. ()
44. Ensor CR, Rihtarchik LC, Morrell MR, Hayanga JW, Lichvar AB, Pilewski JM, Wisniewski S, Johnson BA, DCunha J, Zeevi A, McDyer JF (2017). Rescue alemtuzumab for refractory acute cellular rejection and bronchiolitis obliterans syndrome after lung transplantation. Clin Transplant, 31(4). ()
45. Choi J, Hergenroeder AL, Burke L, Dabbs AD, Morrell M, Saptono A, Parmanto B (2016). Delivering an in-Home Exercise Program via Telerehabilitation: A Pilot Study of Lung Transplant Go (LTGO). Int J Telerehabil, 8(2), 15-26. ()
46. Mahesh B, Bhama JK, Odell DD, Hayanga AJ, Bermudez CA, Morrell MR, Crespo MM, Pilewski JM, Johnson BA, Luketich JD, DCunha J, Shigemura N (2016). Surgical Strategy for Lung Transplantation in Adults With Small Chests: Lobar Transplant Versus a Pediatric Donor. Transplantation, 100(12), 2693-2698. ()
47. DAngelo AM, Chan EG, Hayanga JW, Odell DD, Pilewski J, Crespo M, Morrell M, Shigemura N, Luketich J, Bermudez C, Althouse AD, DCunha J (2016). Atrial arrhythmias after lung transplantation: Incidence and risk factors in 652 lung transplant recipients. J Thorac Cardiovasc Surg, 152(3), 901-9. ()
48. Crespo MM, Bermudez CA, Dew MA, Johnson BA, George MP, Bhama J, Morrell M, DCunha J, Shigemura N, Richards TJ, Pilewski JM (2015). Lung Transplant in Patients with Scleroderma Compared with Pulmonary Fibrosis. Short- and Long-Term Outcomes. Ann Am Thorac Soc, 13(6), 784-92. ()
49. Chan EG, Bianco V 3rd, Richards T, Hayanga JW, Morrell M, Shigemura N, Crespo M, Pilewski J, Luketich J, DCunha J (2015). The ripple effect of a complication in lung transplantation: Evidence for increased long-term survival risk. J Thorac Cardiovasc Surg, 151(4), 1171-9. ()
50. Morrell MR, Pilewski JM (2016). Lung Transplantation for Cystic Fibrosis. Clin Chest Med, 37(1), 127-38. ()
51. Hayanga AJ, Aboagye JK, Hayanga HE, Morrell M, Huffman L, Shigemura N, Bhama JK, DCunha J, Bermudez CA (2014). Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry. J Heart Lung Transplant, 34(2), 182-8. ()
52. Morrell MR, Pilewski JM, Gries CJ, Pipeling MR, Crespo MM, Ensor CR, Yousem SA, DCunha J, Shigemura N, Bermudez CA, McDyer JF, Zeevi A (2014). De novo donor-specific HLA antibodies are associated with early and high-grade bronchiolitis obliterans syndrome and death after lung transplantation. J Heart Lung Transplant, 33(12), 1288-94. ()
53. Ortiz-Pujols S, Jones SW, Short KA, Morrell MR, Bermudez CA, Tilley SL, Cairns BA (2014). Management and sequelae of a 41-year-old jehovah's witness with severe anhydrous ammonia inhalation injury. J Burn Care Res, 35(3), e180-3. ()
54. Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, Bermudez C, Hunter JG, Toyoda Y, Pilewski J, Luketich JD, Jobe BA (2011). Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg, 146(9), 1041-7. ()
55. Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ (2010). Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant, 29(5), 531-7. ()
56. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009). The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant, 29(4), 424-31. ()
57. Morrell MR, Micek ST, Kollef MH (2009). The management of severe sepsis and septic shock. Infect Dis Clin North Am, 23(3), 485-501. ()
58. Lawrence KL, Morrell MR, Storch GA, Hachem RR, Trulock EP (2009). Clinical outcomes of solid organ transplant recipients with ehrlichiosis. Transpl Infect Dis, 11(3), 203-10. ()
59. Morrell MR, Patterson GA, Trulock EP, Hachem RR (2008). Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant, 28(1), 96-100. ()
60. Morrell MR, Dallas J, Kollef MH (2008). A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. Chest, 134(2), 442-446. ()
61. Shorr AF, Lazarus DR, Sherner JH, Jackson WL, Morrell M, Fraser VJ, Kollef MH (2007). Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia. Crit Care Med, 35(4), 1077-83. ()
62. Wu CW, Morrell MR, Heinze E, Concoff AL, Wollaston SJ, Arnold EL, Singh R, Charles C, Skovrun ML, FitzGerald JD, Moreland LW, Kalunian KC (2005). Validation of American College of Rheumatology classification criteria for knee osteoarthritis using arthroscopically defined cartilage damage scores. Semin Arthritis Rheum, 35(3), 197-201. ()
63. Morrell M, Fraser VJ, Kollef MH (2005). Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother, 49(9), 3640-5. ()

Case Report

1. Chan PG, Sanchez PG, Morrell MR, Kilic A, Sultan I (2019). Concomitant surgical aortic valve replacement with bilateral orthotopic lung transplantation. J Card Surg, 35(2), 470-472. ()
2. Harano T, Haidar G, Schaheen L, Morrell MR, Pilewski JM, DCunha J (2019). Successful lung transplantation from a hepatitis C RNA-positive donor to a hepatitis C treatment-experienced recipient with cystic fibrosis. J Thorac Cardiovasc Surg, 158(4), e155-e157. ()
3. George MP, Novelli EM, Shigemura N, Simon MA, Feingold B, Krishnamurti L, Morrell MR, Gries CG, Haider S, Johnson BA, Crespo MM, Bhama JK, Bermudez C, Yousem SA, Toyoda Y, Champion HC, Pilewski JM, Gladwin MT (2013). First successful lung transplantation for sickle cell disease with severe pulmonary arterial hypertension and pulmonary veno-occlusive disease. Pulm Circ, 3(4), 952-8. ()

Editorial

1. Chan EG, Harano T, Morrell MR, Sanchez PG (2021). Lung transplantation protocols during the COVID-19 pandemic: a single center experience. J Thorac Dis, 13(4), 2081-2086. ()
2. Martinu T, Koutsokera A, Benden C, Cantu E, Chambers D, Cypel M, Edelman J, Emtiazjoo A, Fisher AJ, Greenland JR, Hayes D Jr, Hwang D, Keller BC, Lease ED, Perch M, Sato M, Todd JL, Verleden S, von der Thsen J, Weigt SS, Keshavjee S, bronchoalveolar lavage standardization workgroup (2020). International Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation. J Heart Lung Transplant, 39(11), 1171-1190. ()

News

• Lung Transplant: Is it for You?
• Double Lung Transplant Gives Mom of Three a Second Chance at Life
• Kil's Inspiring Double Lung Transplant Story

Podcasts

• How to Choose a Lung Transplant Program